drugset / Trial / NCT04017052
Application of a TBE-Vaccine in Obese Persons
NaSingle-groupOpen-labelPrevention
Summary
Obese people have an altered immune responsiveness. The present study investigates whether this influences immune responses to booster vaccinations (i. e. booster vaccination with TBE vaccine "FSME Immun") and if a modification of vaccination schedules is needed. Obese adults (BMI \>30) \>18 - 60 years are compared with adults with normal weight (BMI \<25) concerning TBE-NT- antibody titers, TBE- NT antibody titer course and cellular immunity. Metabolic parameters and sexual hormones will be tested and compared as well.
Timeline
- Start
- 2015-04-15
- Primary completion
- 2020-02-07
- Completion
- 2020-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FSME-IMMUN Vaccine | Vaccine | — | Intramuscular |